Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥153.30 Million ≈ $22.43 Million USD) by net assets (CN¥8.80 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Chase Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Tianjin Chase Sun Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DOMS Industries Limited
NSE:DOMS
|
0.046x |
|
Arteche Lantegi Elkartea SA
MC:ART
|
0.249x |
|
CEAT Limited
NSE:CEATLTD
|
0.191x |
|
SKYWORTH GRP UNSP.ADR/30
F:KYW0
|
N/A |
|
Xianheng International Science & Technology Co Ltd
SHG:605056
|
N/A |
|
Killam Apartment Real Estate Investment Trust
TO:KMP-UN
|
0.017x |
|
Harbin Electric Coporation Jiamusi Electric Machine Co Ltd
SHE:000922
|
0.028x |
|
SoftwareONE Holding AG
SW:SWON
|
0.171x |
Annual Cash Flow Conversion Efficiency for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Tianjin Chase Sun Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.80 Billion ≈ $1.29 Billion |
CN¥852.24 Million ≈ $124.71 Million |
0.097x | -43.86% |
| 2023-12-31 | CN¥8.87 Billion ≈ $1.30 Billion |
CN¥1.53 Billion ≈ $223.90 Million |
0.173x | +95.92% |
| 2022-12-31 | CN¥8.46 Billion ≈ $1.24 Billion |
CN¥745.35 Million ≈ $109.07 Million |
0.088x | +78.85% |
| 2021-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥391.60 Million ≈ $57.30 Million |
0.049x | +85.09% |
| 2020-12-31 | CN¥7.39 Billion ≈ $1.08 Billion |
CN¥196.66 Million ≈ $28.78 Million |
0.027x | -12.96% |
| 2019-12-31 | CN¥7.07 Billion ≈ $1.03 Billion |
CN¥216.10 Million ≈ $31.62 Million |
0.031x | -48.22% |
| 2018-12-31 | CN¥6.58 Billion ≈ $962.28 Million |
CN¥388.19 Million ≈ $56.81 Million |
0.059x | -48.25% |
| 2017-12-31 | CN¥6.51 Billion ≈ $952.41 Million |
CN¥742.38 Million ≈ $108.63 Million |
0.114x | +53.72% |
| 2016-12-31 | CN¥6.04 Billion ≈ $883.64 Million |
CN¥448.08 Million ≈ $65.57 Million |
0.074x | +224.40% |
| 2015-12-31 | CN¥5.29 Billion ≈ $774.07 Million |
CN¥121.00 Million ≈ $17.71 Million |
0.023x | -64.02% |
| 2014-12-31 | CN¥2.36 Billion ≈ $345.13 Million |
CN¥149.94 Million ≈ $21.94 Million |
0.064x | -24.62% |
| 2013-12-31 | CN¥1.70 Billion ≈ $249.14 Million |
CN¥143.60 Million ≈ $21.01 Million |
0.084x | -23.17% |
| 2012-12-31 | CN¥1.39 Billion ≈ $202.91 Million |
CN¥152.21 Million ≈ $22.27 Million |
0.110x | +223.42% |
| 2011-12-31 | CN¥1.05 Billion ≈ $153.65 Million |
CN¥35.64 Million ≈ $5.22 Million |
0.034x | -19.44% |
| 2010-12-31 | CN¥1.10 Billion ≈ $160.63 Million |
CN¥46.25 Million ≈ $6.77 Million |
0.042x | -71.09% |
| 2009-12-31 | CN¥926.88 Million ≈ $135.63 Million |
CN¥135.06 Million ≈ $19.76 Million |
0.146x | -76.47% |
| 2008-12-31 | CN¥125.51 Million ≈ $18.37 Million |
CN¥77.74 Million ≈ $11.38 Million |
0.619x | -47.33% |
| 2007-12-31 | CN¥61.24 Million ≈ $8.96 Million |
CN¥72.01 Million ≈ $10.54 Million |
1.176x | +1943.30% |
| 2006-12-31 | CN¥21.28 Million ≈ $3.11 Million |
CN¥1.22 Million ≈ $179.15K |
0.058x | -- |
About Tianjin Chase Sun Pharmaceutical Co Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves th… Read more